Analytical CRO devoted to bioanalysis, analytical develoment and quality control of small molecules, biologics and nucleic acids for pharma & biotech companies
๐๐ Upgrading an older Mastersizer or Zetasizer platform? New hardware is easy, ensuring data continuity and GMP compliance is the real challenge.
Our latest article breaks down the essentials of a successful method transfer.
๐ kymos.com/news/mastersizer-2โฆ#GMP#ICHQ14
๐ฅ A look back at our #FamilyDay!
As part of our 25th anniversary celebrations, we welcomed the families and loved ones of our colleagues for a day of lab tours, shared experiences, and great company.
Watch the highlights below! ๐
#KymosGroup#LifeAtKymos
โถ๏ธ We're live at #AFI2026!
Our team is ready to welcome visitors at Booth 96 in Rimini.
If you're attending the symposium, stop by to meet Luca Gramaccioni and Alexandros Chatgilialoglu and learn how Kymos Group supports pharmaceutical development.
๐ธ Last Saturday, we celebrated #FamilyDay at Kymos Group, welcoming the families and loved ones of our colleagues to our Cerdanyola del Vallรจs site as part of our 25th anniversary celebrations.
Take a look at some of our favourite moments, and stay tuned for the official video!
๐ข Attending #AFI2026 on June 11?
Visit Kymos Group Talent Corner at Booth 96 and meet Alessandra Rossi, HR Specialist at Kymos Italy.
Learn about career opportunities, ask your questions, and leave us your CV.
๐ Rimini | June 11
#PharmaJobs#BiotechJobs#LifeSciences
โถ๏ธ Luca Gramaccioni and Alexandros Chatgilialoglu will be representing Kymos Group at #AFI2026 in Rimini, Italy, on June 10โ12.
Looking forward to connecting with pharmaceutical industry professionals and discussing how Kymos Group supports drug development.
18 years of scientific dedication, collaboration, and bioanalytical support culminated in a major regulatory milestone.
We're proud to have contributed to a programme that will help bring a new treatment option to patients.
Check out the full story ๐
linkedin.com/feed/update/urnโฆ
๐ #Biodistribution and #SheddingStudies are becoming increasingly important in the development of new therapeutic modalities.
Our latest article explores their differences, regulatory expectations, and the analytical approaches used to support them.
๐ kymos.com/news/biodistributiโฆ
Celebrating 25 years of Kymos Group๐ฌ
In our latest anniversary spotlight, we recognize Lluรฏsa Garcรญa Pรฉrez, Site General Manager Spain and one of Kymosโ founding members, whose leadership has helped shape the company from its very beginning.
#Kymos25#KymosGroup#LifeSciences
โถ๏ธ Boris Benoit, Business Developer France at Kymos Group, will be attending #ICGT2026 on May 27โ28 in Gentilly, France!
Looking forward to connecting with experts across the #CellTherapy and #GeneTherapy field and discussing how Kymos Group supports advanced therapies.
25 years of Kymos Group: taking Kymos on the road ๐ฌ
This picture shows one of our first congress stands, back in Valencia in 2002, with our founding members representing Kymos during its early days.
More than two decades later, congresses remain an important part of our job.
๐๐ The new ICH Q1 guideline is set to reshape stability testing for biologics, vaccines, ATMPs, oligonucleotides, etc
In our latest blog article, we explore the changes introduced by the new framework and what companies should start preparing for.
๐ kymos.com/news/ich-q1-stabilโฆ
Kymos Group will be attending the MabDesign Partnering Day 2026 ๐ซ๐ท
Boris Benoit, Business Developer France, will be on site for a day of networking, B2B meetings, and discussions with the biotherapy ecosystem.
๐ 3 June 2026
๐ Craponne / Lyon, France
Kymos Group is attending the University of Camerino Career Day ๐
Luca Gramaccioni and Alessandra Rossi will be there to meet students and young professionals interested in the pharma and biotech sectors and share career opportunities.
๐ 13 May | ๐ Camerino, Italy
#ConnectionDay2026 is live at World Trade Center Barcelona!
Our team is on site connecting with partners and exploring new collaborations across the catalan life sciences ecosystem.
๐ 6 May
๐ Barcelona
Come say hi! ๐
๐ Validating cannabinoid bioanalysis isnโt straightforward. Measuring CBD, THC and their metabolites in plasma requires sensitivity, selectivity and robust methods.
We present a 6-analyte LC-MS/MS approach with low LOQ in our latest article:
๐ kymos.com/news/cannabinoid-bโฆ
BIOKOREA 2026 is live in Seoul ๐ฐ๐ท
Cosme Aragonรฉs and Yoonjin Kim are on site at COEX, connecting with partners across the global bio-health industry.
๐ 28โ30 April |๐ Seoul
Come say hi! ๐
Kymos Group is attending the Cell & Gene Meeting on the Med in Rome this week ๐ฎ๐น
Our BD for Italy & South Mediterranean, Alexandros Chatgilialoglu, will be there to connect and explore new collaborations.
๐ 28โ30 April | ๐ Rome Cavalieri Hotel
๐ฉ alexandros@kymos.com
โถ๏ธ This Sunday, Kymos Group joined the Magic Line Sant Joan de Dรฉu in Barcelona.
~50 colleagues walked 9 km together, supporting a shared cause.
Thanks to everyone who made it happen.
#MagicLineSJD#SantJoanDeDeu#KymosGroup#Volunteering